Publish Draft, Revised, or Final Guidance on Digital Health Technologies |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
12/21/2021 |
Launch Rare Disease Endpoint Advancement Pilot Program |
Advancing Development of Drugs for Rare Diseases |
9/30/2022 |
Develop STAR webpage |
Split Real Time Application Review (STAR) Pilot Program |
10/1/2022 |
Publish FRN on Paired Meeting Program |
Enhancing Capacity to Review Complex Innovative Designs |
10/20/2022 |
Publish FRN Announcing CMC Development and Readiness Pilot |
Facilitating Chemistry, Manufacturing, and Controls Readiness for Products with Accelerated Clinical Development |
10/31/2022 |
Publish MAPP on Approaches to Meet CMC Challenges |
Facilitating Chemistry, Manufacturing, and Controls Readiness for Products with Accelerated Clinical Development |
11/1/2022 |
Patient-Focused Drug Development Listening Meeting on Gene Therapy Products |
Patient-Focused Drug Development |
11/15/2022 |
Publish FRN on Continuation of MIDD |
Advancing Model-Informed Drug Development |
1/11/2023 |
Conduct DHT Public Meeting 1 |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
1/31/2023 |
Publish Website of DHT Committee |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
2/28/2023 |
Conduct Public Workshop on Negative Controls |
Optimization of the Sentinel Initiative |
3/8/2023 |
Establish DHT Framework Document |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
3/23/2023 |
Publish Capacity Planning Implementation Plan |
Resource Capacity Planning Implementation |
3/29/2023 |
Issue RFI for PFDD |
Enhancing the Incorporation of the Patient’s Voice in Drug Development and Decision-Making |
5/2/2023 |
Conduct Innovative Manufacturing Public Workshop |
Advancing Utilization and Implementation of Innovative Manufacturing |
6/8/2023 |
Conduct Public Meeting Financial Plan FY23 |
Financial Transparency |
6/8/2023 |
Update Four-Part Harmony MAPP |
Enhancing Communication Between FDA and Sponsors During Application Review |
8/25/2023 |
Conduct Public Workshop on Post Market Pregnancy Data |
Optimization of the Sentinel Initiative |
9/18/2023 |
Develop and Update Data and Technology Modernization Strategy FY23 |
Develop Data and Technology Modernization Strategy |
9/19/2023 |
Publish Draft, Revised, or Final Guidance on Drug Use Related Software |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
9/19/2023 |
Publish Revised Draft Guidance on Formal Meetings Between FDA and Sponsors |
Guidance, Clarity, and Transparency |
9/22/2023 |
Publish Draft Guidance on Alternative Tools to Assess Manufacturing Facilities |
Alternative Tools to Assess Manufacturing Facilities Named in Pending Applications |
9/22/2023 |
Issue Federal Register Notice Summarizing PFDD RFI |
Enhancing the Incorporation of the Patient’s Voice in Drug Development and Decision-Making |
12/13/2023 |
Publish Public Report on Challenges and Barriers to Cloud Technologies |
Leverage Cloud Technology to Progress Regulatory Digital Transformation |
12/27/2023 |
Conduct Public Workshop for CID |
Enhancing Capacity to Review Complex Innovative Designs |
3/5/2024 |
Publish Capacity Planning Implementation Plan Updates FY24 |
Resource Capacity Planning Implementation |
3/22/2024 |
Issue New Policies and Procedures for Reviewing Methodological Approaches and Study Protocols for REMS |
Modernization and Improvement of REMS Assessments |
3/25/2024 |
Update Existing Policies and Procedures to Systematically Determine if Modifications to REMS are Needed |
Modernization and Improvement of REMS Assessments |
3/25/2024 |
Update Relevant REMS Guidances to Incorporate REMS Assessment Planning into the Design of REMS |
Modernization and Improvement of REMS Assessments |
5/6/2024 |
Conduct Public Meeting Financial Plan FY24 |
Financial Transparency |
6/6/2024 |
Conduct DHT Public Meeting 2 |
Enhancing Use of Digital Health Technologies to Support Drug Development and Review |
6/25/2024 |
Publish Combination Products Guidance Related to URRAs |
Advancing Development of Drug-Device and Biologic-Device Combination Products Regulated by CBER and CDER for Use-Related Risk Analysis (URRA) |
7/8/2024 |
Publish Report on Public Workshop on Post Market Pregnancy Data |
Optimization of the Sentinel Initiative |
7/11/2024 |
Publish Strategy Document on Innovative Manufacturing Technologies |
Advancing the Use and Implementation of Innovative Manufacturing Technologies |
9/11/2024 |
Source